Change in Dosing Regimen

• Example: Protease inhibitor with short plasma half-life

  • Change from TID to BID
  • Expect:
    Similar or higher AUC over 24 hrs.
    Higher Cmax (safety question)
    Lower Cmin (efficacy question)

Previous slide

Next slide

Back to first slide

View graphic version